Companies / Dominican Republic
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Local Firms Evaluate Regional And International Trade Threats
May 2007 | Trade AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Imported generics and contraband medicines are seen by Latin American pharmaceutical producers as primary threats as they deal with the steady advance of US Free Trade Agreements (FTAs) according to a recent forum held in Santo Domingo, Dominican Republic. Notably, while the usual theme of the threat of foreign research-based multinationals featured in reports following the forum, the recent agreement on trade deals in the US between the presidential administration and Congress could mean both a renewed push as well as frictions over efforts to ratify FTAs in Colombia and Panama. Local pharmaceutical players appear set on seeking market